Literature DB >> 21950316

Molecular considerations for development of phage antibody libraries.

Mohammad Reza Tohidkia1, Jaleh Barar, Farzad Asadi, Yadollah Omidi.   

Abstract

Nowadays, phage display libraries are used as robust tools for discovery and evolution of peptide/protein based drugs as well as targeting molecules, in particular monoclonal antibodies (mAbs) and its fragments (i.e., scFvs, Fabs, or bivalent F(ab')₂). Phage display technology, as a molecular diversity approach, enables selection of antibody fragments (e.g., scFv/Fab) with high affinity, specificity and effector functions against various targets. However, such selection process itself is largely dependent upon various molecular factors such as methods for construction of phage library, phage/phagemid vectors, helper phage, host cells and biopanning processes. The current review article provides important molecular considerations for successful development of phage antibody libraries that may be used as a platform for translation of antibody fragments into viable diagnostic/therapeutic reagents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21950316     DOI: 10.3109/1061186X.2011.611517

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  16 in total

Review 1.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

Review 2.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

Review 3.  Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.

Authors:  R L Juliano; Xin Ming; Kyle Carver; Brian Laing
Journal:  Nucleic Acid Ther       Date:  2014-01-02       Impact factor: 5.486

Review 4.  Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.

Authors:  Soo Ghee Yeoh; Jia Siang Sum; Jing Yi Lai; W Y Haniff W Isa; Theam Soon Lim
Journal:  J Cardiovasc Transl Res       Date:  2021-08-31       Impact factor: 3.216

Review 5.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 6.  Combinatorial approaches for the identification of brain drug delivery targets.

Authors:  Charles C Stutz; Xiaobin Zhang; Eric V Shusta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library.

Authors:  Mahsa Sorouri; Sean P Fitzsimmons; Antonina G Aydanian; Sonita Bennett; Marjorie A Shapiro
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 8.  Radiolabeled theranostics: magnetic and gold nanoparticles.

Authors:  Saeideh Same; Ayuob Aghanejad; Sattar Akbari Nakhjavani; Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-09-30

9.  A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination.

Authors:  Mohammad A Rafi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-09-10

Review 10.  Computerized techniques pave the way for drug-drug interaction prediction and interpretation.

Authors:  Reza Safdari; Reza Ferdousi; Kamal Aziziheris; Sharareh R Niakan-Kalhori; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.